Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 24.14
Key Takeaways
Risk factor
Strong & resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Decent dividends
Data is available to registered users only
Data is available to registered users only
About
Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based in Xinchang, China.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Data is available to registered users only
Buy
Sell